Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control

Hospital de Clinicas de Porto Alegre112 enrolled

Overview

This is a prospective, intervention, randomized, phase IV study. Patients will be included with 60 years or older, both sexes, with HbA1c \>8.5% using oral antidiabetics agents and insulin and then we will be randomized by use syringe or pens device to use insulin NPH and regular. All patients will receive a blood glucose monitor, lancet tapes, capillary blood glucose tests (3 tests/day). HbA1c will be measured at baseline, 3 and 6 months. Patients will see monthly.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

112

Conditions

Diabetes

Interventions

Pens DeviceDEVICE

Eligibility

Sex: ALLMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Sixty years or older * Diabetes type 2 with Glycated Hemoglobin higher than 8.5% * Using or necessity to use insulin * Using syringe to insulin * Using at least one oral antidiabetic * Accept to participate Exclusion Criteria: * Glomerular Filtration Rate lower than 30 * Considering unfit for self administration of insulin

Locations (1)

Rafael Vaz Machry

Porto Alegre, Rio Grande do Sul, Brazil

RECRUITING